Literature DB >> 17190001

Early events in the thymus affect the balance of effector and regulatory T cells.

Daniel J Pennington1, Bruno Silva-Santos, Tobias Silberzahn, Mónica Escórcio-Correia, Martin J Woodward, Scott J Roberts, Adrian L Smith, P Julian Dyson, Adrian C Hayday.   

Abstract

In cellular immunology the critical balance between effector and regulatory mechanisms is highlighted by serious immunopathologies attributable to mutations in Foxp3, a transcription factor required for a major subset of regulatory T (Tr) cells. Thus, many studies have focused on the developmental origin of Tr cells, with the prevailing view that they emerge in the thymus from late-stage T-cell progenitors whose T-cell receptors (TCRs) engage high affinity (agonist) ligands. This study questions the completeness of that interpretation. Here we show that without any obvious effect on TCR-mediated selection, the normal differentiation of mouse gammabeta T cells into potent cytolytic and interferon-gamma-secreting effector cells is switched towards an aggregate regulatory phenotype by limiting the capacity of CD4+CD8+ T-cell progenitors to influence in trans early gammabeta cell progenitors. Unexpectedly, we found that the propensity of early TCR-alphabeta+ progenitors to differentiate into Foxp3+ Tr cells is also regulated in trans by CD4+CD8+ T-cell progenitor cells, before agonist selection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17190001     DOI: 10.1038/nature06051

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  44 in total

Review 1.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

2.  The essential function for serum response factor in T-cell development reflects its specific coupling to extracellular signal-regulated kinase signaling.

Authors:  Anastasia Mylona; Robert Nicolas; Diane Maurice; Mathew Sargent; David Tuil; Dominique Daegelen; Richard Treisman; Patrick Costello
Journal:  Mol Cell Biol       Date:  2010-11-22       Impact factor: 4.272

Review 3.  Advancements in immune tolerance.

Authors:  Ping-Ying Pan; Junko Ozao; Zuping Zhou; Shu-Hsia Chen
Journal:  Adv Drug Deliv Rev       Date:  2007-10-05       Impact factor: 15.470

Review 4.  Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target.

Authors:  Dorothy K Sojka; Yu-Hui Huang; Deborah J Fowell
Journal:  Immunology       Date:  2008-03-14       Impact factor: 7.397

Review 5.  The development and function of regulatory T cells.

Authors:  Creg J Workman; Andrea L Szymczak-Workman; Lauren W Collison; Meenu R Pillai; Dario A A Vignali
Journal:  Cell Mol Life Sci       Date:  2009-04-24       Impact factor: 9.261

Review 6.  The T-cell receptor repertoire of regulatory T cells.

Authors:  Rafal Pacholczyk; Joanna Kern
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

Review 7.  Regulatory T cells exert checks and balances on self tolerance and autoimmunity.

Authors:  Kajsa Wing; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

Review 8.  Immune therapies.

Authors:  Rao H Prabhala; Nikhil C Munshi
Journal:  Hematol Oncol Clin North Am       Date:  2007-12       Impact factor: 3.722

9.  Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development.

Authors:  Jane E Willoughby; Patrick S Costello; Robert H Nicolas; Nicholas J Robinson; Gordon Stamp; Fiona Powrie; Richard Treisman
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

10.  Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection.

Authors:  Anthony B Nesburn; Ilham Bettahi; Gargi Dasgupta; Alami Aziz Chentoufi; Xiuli Zhang; Sylvaine You; Naoyuki Morishige; Andrew J Wahlert; Donald J Brown; James V Jester; Steven L Wechsler; Lbachir BenMohamed
Journal:  J Virol       Date:  2007-05-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.